Quality of Life as a Major Determinant of Medical Decision-Making
In this paper, I shall mainly consider the second part of the question: Not so much who defines quality of life; we know that it has been or can be done by several categories: philosophers, social scientists, physicians, companies (especially pharmaceutical companies), health administration, government ... But rather who makes medical-decisions and how determination of quality of life and other determinants may contribute to a medical decision (1). Medical decisions are mainly made by physicians, but through quality of life or other determinants, the other categories contribute to this decision.
KeywordsAllogeneic Bone Marrow Transplantation Autologous Bone Marrow Transplantation Health Administration Genous Leukemia Patient Individual Preference
Unable to display preview. Download preview PDF.
- 5.Zittoun R., Suciu S., Solbu G et al. Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - allogeneic or autologous - or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8 A study. Blood 1995, 86, supp’. I: 433a.Google Scholar